Earnings Call · Q4 FY2025·2026-02-27

Q4 25EPS -4.88%·Rev n/aQ3 25EPS -10.81%·Rev n/aQ2 25EPS -41.94%·Rev n/aQ1 25EPS -54.47%·Rev n/a⚠ consensus missing

ALX ONCOLOGY HOLDINGS INC ALXO

Jason Lettmann — Executive

Barbara Klencke — Executive

Harish Shantharam — Executive

−10.2%1d on move date−9.7% vs SPY3d−11.9%5d−9.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALXO calls or request research access.

More ALXO calls Browse calls Request research access